GlassScriptPhysician profile
John Y Ko
NPI 1972605541
$10,502.53
in general payments reported to CMS, 2019-2025
10 companies · $3,022 in 2025
The $3,022 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $343 · 2021: $1,837 · 2022: $1,978 · 2023: $1,596 · 2024: $1,296 · 2025: $3,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,818 · Travel and Lodging: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,817.78 |
| Travel and Lodging | $1,095.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,815.49 | 2021-2025 | Ffrangio, Onyx Frontier, Telescope |
| Boston Scientific Corporation | $3,152.62 | 2019-2025 | Opticross, Synergy, Avvigo Guidance System |
| Abbott Laboratories | $2,304.81 | 2019-2025 | Triclip, Dragonfly Opstar, Coroflow |
| Shockwave Medical, INC | $450.21 | 2022-2025 | |
| Abiomed | $288.71 | 2022-2023 | Impella |
| Chiesi USA, INC. | $147.47 | 2019-2022 | |
| Teleflex LLC | $135.50 | 2021 | |
| Medtronic Vascular, INC. | $105.99 | 2019 | |
| Edwards Lifesciences Corporation | $83.81 | 2023 | Sapien 3 Ultra Resilia, Pascal |
| Terumo Medical Corporation | $17.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.